77
Diseases characterised by Parenchymal opacification Shivaprakash B Hiremath DNB Resident

Diseases Characterised by Parenchymal Opacification

Embed Size (px)

Citation preview

Page 1: Diseases Characterised by Parenchymal Opacification

Diseases characterised by Parenchymal opacification

Shivaprakash B HiremathDNB Resident

Page 2: Diseases Characterised by Parenchymal Opacification

Normal lung density

•Slightly higher than air

Air in airspaces and small airways

Interstitial lung tissues

Wall of the alveoli

Small airways

Capillaries, blood in these

Vs

Page 3: Diseases Characterised by Parenchymal Opacification

Increased lung opacity< in the amount of air

> size / volume of soft tissues

• Reduction in the volume (expansion) of the airspaces

• Partial or total replacement of the air in the airspaces by fluid or cells

• Increase in blood flow and blood volume in vessels

• Thickening of the interstitial tissues and of the alveolar wall

Page 4: Diseases Characterised by Parenchymal Opacification

Degree of Opacification

•“Ground-glass opacity” - hazy increase in lung opacity that does not obscure the underlying vessels and bronchi

•“Lung consolidation” or “consolidation” - vessels and bronchial walls are obscured

Page 5: Diseases Characterised by Parenchymal Opacification
Page 6: Diseases Characterised by Parenchymal Opacification

•“Increased lung attenuation that have a density that is greater than soft tissue density”▫Development of calcifications within

existing lesions ▫Deposition of calcium within the lung

parenchyma ▫Diffuse or multifocal pulmonary ossification

Page 7: Diseases Characterised by Parenchymal Opacification

Ground Glass Opacity

• Patchy distribution of ground-glass opacity Pneumocystis jiroveci pneumonia

Focal Vs Diffuse

Page 8: Diseases Characterised by Parenchymal Opacification

Focal Vs Diffuse

Ground Glass Opacity

Diffuse ground-glass opacity Hypersensitivitypneumonitis

Page 9: Diseases Characterised by Parenchymal Opacification

• Pulmonary haemorrhage in the right middle lobe

• Ill-defined GGO

• Sharply defined area of GGO in RUL• Pulmonary haemorrhage

GGO located near centre of the secondary pulmonarylobules and then look like ill-defined nodules

Page 10: Diseases Characterised by Parenchymal Opacification

Reduction of Air in the Airspaces

•Volume Loss of the Alveoli▫Physiological phenomenon – development

of ground-glass opacity▫Increase in density in dependent lung

regions Lower lung > Middle and upper zones

Greater diaphragmatic movement Gravitational effectProne scans

Dependent density is no longer visible against the posterior chest wall and may appear against the anterior chest wall

Page 11: Diseases Characterised by Parenchymal Opacification

•Volume Loss of the Alveoli▫Pathological changes in the lung and pleura

Fibrotic scarring in the lung Pleural thickening

Restrict lung expansion Ground-glass opacity

Page 12: Diseases Characterised by Parenchymal Opacification

Decreased expansion right lung due to Right-sided malignant mesothelioma

Page 13: Diseases Characterised by Parenchymal Opacification

•Replacement of Alveolar Air▫Partial filling of the alveolar spaces by fluid or

cells Alveolar proteinosis Respiratory bronchiolitis, bronchiolitis Interstitial lung disease Alveolar haemorrhage Bronchioloalveolar cell carcinoma

•Partial filling of the alveolar spaces + Thickening of the interstitium, alveolar walls = Crazy paving

Page 14: Diseases Characterised by Parenchymal Opacification

Alveolar proteinosis• Areas of ground-glass opacity with intralobular reticular

pattern superimposed creating the crazy-paving pattern

Page 15: Diseases Characterised by Parenchymal Opacification

• Increase in Parenchymal Perfusion▫> in capillary blood volume = > in lung

density▫Mosaic perfusion = Areas with >

attenuation (GGO) + < attenuation

Page 16: Diseases Characterised by Parenchymal Opacification

Mosaic perfusionDecreased attenuation Increased lung attenuation

• Narrowing or obstruction of the blood vessels

• Small airways narrowing▫ Reflex vasoconstriction

• Redistribution of blood flow

GGO Vs Mosaic perfusionCalibre of the blood vesselsDelineation of the ground-glass opacityDensity changes after deep expiration

Page 17: Diseases Characterised by Parenchymal Opacification

• Mosaic perfusion secondary to recurrent pulmonary embolism

Page 18: Diseases Characterised by Parenchymal Opacification

Thickening of Parenchymal Interstitium / Alveolar Wall

•Minimal thickening of the alveolar wall, parenchymal interstitium = groundglass opacity

•Inflammation or infiltration•Intraalveolar cellular infiltrate, filling the

airspaces•Acute inflammation i.e indicating active

disease or reactivation of disease

Page 19: Diseases Characterised by Parenchymal Opacification

•GGO ▫Fibrosis and result from fibrotic thickening

of the alveolar wall and interstitium•Be careful to diagnose GGO as an active

process▫Traction bronchiectasis or honeycombing

Page 20: Diseases Characterised by Parenchymal Opacification

• Usual interstitial pneumonia in Systemic sclerosis• GGO in the dorsal and basal subpleural region of both

lungs, i.e active lung disease

Page 21: Diseases Characterised by Parenchymal Opacification

•When a lung biopsy is performed, areas of ground-glass opacity are the best locations to be targeted, especially when no signs of fibrosis are present

Page 22: Diseases Characterised by Parenchymal Opacification

• Diffuse ground-glass opacity in chronic hypersensitivity pneumonitis

• Bronchial deformation indicates pulmonary fibrosis

Page 23: Diseases Characterised by Parenchymal Opacification

Acute Versus Subacute or Chronic Disease

Page 24: Diseases Characterised by Parenchymal Opacification

Crazy-Paving Pattern

•Superposition of a linear pattern on ground-glass opacity = Crazy paving

•Pulmonary alveolar proteinosis

Page 25: Diseases Characterised by Parenchymal Opacification

• Acute radiation pneumonitis in a patient treated for left-sided breast cancer

• Ground-glass opacity and consolidation

• Faint intralobular reticular pattern

• Crazy-paving pattern

Page 26: Diseases Characterised by Parenchymal Opacification

Lung Consolidation

•Increase in lung density with obscuration of the underlying vessels & bronchial walls

•Bronchi can be recognised as an air bronchogram, i.e. low-density branching tubular structures

•Lung consolidation are similar to the lung changes that are responsible for ground-glass opacity

Page 27: Diseases Characterised by Parenchymal Opacification

•Most frequent cause is a decrease in the amount of air in the airspaces

•Replacement of this air by fluid, cells, tissue or other substances

•Interstitial pneumonia (UIP)•Sarcoidosis

Page 28: Diseases Characterised by Parenchymal Opacification

• Subpleural areas of lung consolidation• Eosinophilic pneumonia

Page 29: Diseases Characterised by Parenchymal Opacification

Consolidation margins

•Consolidation has one or more sharply defined borders because the pathology reaches an anatomic structure such as a fissure

•Borders of consolidation that are not adjacent to the fissure may be,▫Sharply defined ▫Irregular and blurred▫Possibly surrounded with ground-glass

opacity

Page 30: Diseases Characterised by Parenchymal Opacification

Sharp delineation by major fissure

• Lung consolidation and ground-glass opacity in a patient with overwhelming pneumonia

Page 31: Diseases Characterised by Parenchymal Opacification

• Pulmonary infection with lung consolidation and GGO

Page 32: Diseases Characterised by Parenchymal Opacification

•Airspace filling is the most frequent cause of consolidation, this pattern is often associated with,▫presence of centrilobular airspace nodules -

early airspace filling, ▫i.e bronchial distribution

Page 33: Diseases Characterised by Parenchymal Opacification

Diseases producing ID-GGO:

•Diffuse pneumonias•Primarily opportunistic infections•Chronic interstitial diseases•Acute alveolar diseases•Unusual miscellaneous disorders

Page 34: Diseases Characterised by Parenchymal Opacification
Page 35: Diseases Characterised by Parenchymal Opacification
Page 36: Diseases Characterised by Parenchymal Opacification
Page 37: Diseases Characterised by Parenchymal Opacification
Page 38: Diseases Characterised by Parenchymal Opacification
Page 39: Diseases Characterised by Parenchymal Opacification
Page 40: Diseases Characterised by Parenchymal Opacification
Page 41: Diseases Characterised by Parenchymal Opacification
Page 42: Diseases Characterised by Parenchymal Opacification
Page 43: Diseases Characterised by Parenchymal Opacification
Page 44: Diseases Characterised by Parenchymal Opacification
Page 45: Diseases Characterised by Parenchymal Opacification
Page 46: Diseases Characterised by Parenchymal Opacification
Page 47: Diseases Characterised by Parenchymal Opacification
Page 48: Diseases Characterised by Parenchymal Opacification
Page 49: Diseases Characterised by Parenchymal Opacification
Page 50: Diseases Characterised by Parenchymal Opacification
Page 51: Diseases Characterised by Parenchymal Opacification
Page 52: Diseases Characterised by Parenchymal Opacification
Page 53: Diseases Characterised by Parenchymal Opacification
Page 54: Diseases Characterised by Parenchymal Opacification
Page 55: Diseases Characterised by Parenchymal Opacification
Page 56: Diseases Characterised by Parenchymal Opacification
Page 57: Diseases Characterised by Parenchymal Opacification
Page 58: Diseases Characterised by Parenchymal Opacification
Page 59: Diseases Characterised by Parenchymal Opacification
Page 60: Diseases Characterised by Parenchymal Opacification
Page 61: Diseases Characterised by Parenchymal Opacification
Page 62: Diseases Characterised by Parenchymal Opacification
Page 63: Diseases Characterised by Parenchymal Opacification
Page 64: Diseases Characterised by Parenchymal Opacification
Page 65: Diseases Characterised by Parenchymal Opacification
Page 66: Diseases Characterised by Parenchymal Opacification
Page 67: Diseases Characterised by Parenchymal Opacification
Page 68: Diseases Characterised by Parenchymal Opacification
Page 69: Diseases Characterised by Parenchymal Opacification
Page 70: Diseases Characterised by Parenchymal Opacification

Increased Lung Attenuation more than Soft Tissue Density•Multifocal lung calcification•Granulomatous diseases

▫Tuberculosis▫Silicosis Associated with lung

nodules▫Sarcoidosis▫Amyloidosis

Page 71: Diseases Characterised by Parenchymal Opacification

Metastatic calcification

•Deposition of calcium typically within the parenchymal, peribronchovascular interstitium▫Hypercalcaemia – abnormal calcium and

phosphate metabolism▫Chronic renal failure▫Secondary hyperparathyroidism

Page 72: Diseases Characterised by Parenchymal Opacification

•Areas of GGO with calcification that may be inconspicuous or very dense or present as patchy areas of consolidation

•Consolidated lung parenchyma appears abnormally dense

Page 73: Diseases Characterised by Parenchymal Opacification

• Metastatic calcification• Dense centrilobular ground-glass

opacities

Page 74: Diseases Characterised by Parenchymal Opacification

• Metastatic calcification in consolidated lung in chronic renal failure and secondary hyperparathyroidism

Page 75: Diseases Characterised by Parenchymal Opacification

Disseminated pulmonary ossification

•Small deposits of mature bone form within the lung parenchyma▫Chronic heart disease (mitral stenosis)▫Idiopathic pulmonary fibrosis (IPF)▫Asbestosis

Page 76: Diseases Characterised by Parenchymal Opacification
Page 77: Diseases Characterised by Parenchymal Opacification

Amiodarone lung toxicity

•Pulmonary toxic reaction with interstitial pneumonia and fibrosis

•Consolidated lung parenchyma may appear abnormally dense

•Liver and spleen appear abnormally dense as drug accumulates in the organs